| LINE ITEM (USD / %) | FY 2025
FILED 2025-06-30 | FY 2024
FILED 2024-06-30 | FY 2023
FILED 2023-06-30 |
|---|---|---|---|
| Revenue (Total Sales) | $5.3M | $8.8M | $13.5M |
| YoY Revenue Growth % | -40.2% | -34.7% | — |
| Gross Profit | $3.2M | $5.9M | — |
| Gross Margin % | 61.0% | 66.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$2.7M | -$6.6M | -$28.8M |
| Operating Margin % | -52.1% | -75.1% | -80.0% |
| Net Income (GAAP) | -$2.6M | -$6.4M | -$28.6M |
| EBITDA (Normalized) | -$2.7M | -$6.6M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$273.8K | -$5.2M | -$9.2M |
| Capital Expenditures (CapEx) | $21.7K | $31.5K | — |
| Free Cash Flow (FCF) | -$295.4K | -$5.2M | -$9.2M |
| FCF Margin % | -5.6% | -59.5% | -68.0% |
| Return on Invested Capital (ROIC %) | -18.2% | -45.0% | — |
| Cash & Short-Term Equivalents | $3.3M | $8.4M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $15.3M | $17.9M | — |